Patent · US Active

Construction method of Mucor circinelloides cell factory for producing dihomo-gamma-linolenic acid and fermentation technology

US11414650B2 · kind B2 · utility

0Cited by
1References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 12, 2020
Grant dateAug 16, 2022
Priority date
Expiry dateDec 12, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12R2001/785
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present disclosure relates to a construction method of a Mucor circinelloides cell factory for producing dihomo-γ-linolenic acid and a fermentation technology, belonging to the field of genetic engineering. In the present disclosure, γ-linolenic acid elongase gene glelo is obtained from Mortierella alpine by cloning, the gene is ligated to an integrative plasmid pMAT1552, and transformed into a Mucor circinelloides defective strain Mu402, and the gene glelo is integrated into Mucor circinelloides genome through homologous recombination, to obtain the recombinant strain Mc-glelo, and finally, the expression of the gene glelo in Mucor circinelloides is realized. The lipid content in the recombinant strain Mc-glelo is not obviously different from that in the control strain Mc1552, however, the lipid composition changes greatly, and dihomo-γ-linolenic acid appears in the lipids of the recombinant strain Mc-glelo, and the content thereof reaches 5.7% of the total fatty acids. Under optimized fermentation conditions and in the presence of precursor fatty acid, the DGLA content reaches 7.6%. The new recombinant strain was deposited in China General Microbiological Culture Collection C…

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.